* U.S. FDA approves Bayer’s kovaltry antihemophilic factor (recombinant) for treatment of children and adults with hemophilia A
The post BRIEF-U.S. FDA approves Bayer’s drug to treat hemophilia A appeared first on NASDAQ.
Forex – financial instrument.Forex news
* U.S. FDA approves Bayer’s kovaltry antihemophilic factor (recombinant) for treatment of children and adults with hemophilia A
The post BRIEF-U.S. FDA approves Bayer’s drug to treat hemophilia A appeared first on NASDAQ.